// App-Quantinova.ai

e20576 : Treatment patterns and characteristics in the second and third-line therapy setting for real-world small cell lung cancer patients.

Researchers

Presenter

  • Patricia Prince

Principal Investigators

  • Adina Estrin

  • Dylan Supina

  • Rami Ben-Joseph

  • Anne Boccuti

  • Kobby Asubonteng

  • Badri Rengarajan

  • Moshe Fridman

  • Raj Hanvesakul

  • Benjamin Taylor

Medical Centers

  • Aetion Inc., New York, NY, Jazz Pharmaceuticals Inc., Philadelphia, PA, Jazz Pharmaceuticals Inc., Palo Alto, CA

  • AMF Consulting, Los Angeles, CA

  • Jazz Pharmaceuticals,Oxford,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small cell lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

  • Gemcitabine

  • Vinorelbine

  • Tagrisso

  • Vincristine

  • Doxorubicin

  • Decitabine

  • Irinotecan

  • Paclitaxel

  • Pemetrexed

  • Docetaxel

  • Erlotinib hydrochloride

  • Etoposide

  • Etoposide phosphate

  • Nivolumab

  • Denosumab

  • Topotecan Hydrochloride

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved